Skip to content
value.today

908 Devices Inc.

MASS
$503 Mmarket cap on Oct 14, 2026+72.8% since Jan 2024
Compare
World rank
#12,540
Revenue
$56 M
For year ending December-2025
Net income
$19 M
34.7% margin
SEC filing
Employees
96
As on September 2020
value.today research

908 Devices Inc. in brief

908 Devices Inc. is a listed company in the Medical Devices industry, based in Burlington, Massachusetts, USA. Its market value was $503 M on 14 October 2026, which makes it the 12,540th largest listed company in the world and the 2,532nd largest in the USA on this site. In the year to December 2025 it had sales of $56 M and a net profit of $19 M, about 35 cents of profit for every dollar of sales. It employs about 96 people and Kevin J. Knopp is its chief executive. Its largest product and service lines by sales in 2025 were Device sales revenue (65%), Recurring revenue (35%) and Contract revenue (under 1%). By market, the largest shares of its 2025 sales came from USA (73%), Europe, Middle East and Africa (19%) and Asia Pacific (5%). Its shares trade under the symbol MASS (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About 908 Devices Inc.

908 Devices is a chemical and biochemical analysis technology company that crosses industry boundaries, devices provide answers for critical to life questions in life science research, biopharmaceuticals, forensics and more. The company annual revenue is 26.8 million USD and total assets are 178.8 million USD as on 2020. The headquarters is in USA.

908 Devices Inc. timeline

3 events, 2012–2025
  1. 2012
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2020
  4. 🔔
    Initial public offering on Nasdaq
    Final prospectus filed with the SEC on 18 December 2020; shares registered for exchange trading on 17 December 2020.
  5. 2025
  6. 💰
    Record revenue of $56 million
    FY2025, the highest of the 6 years on record.

Events of 908 Devices Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$168 M$335 M$503 M$671 M2023202420252026

World rank over time

▼ down 532 places since 2022
2022-01-07: #12095#12,09520222022-12-25: #17241#17,24120222023-07-30: #17903#17,90320232024-01-05: #15952#15,95220242026-03-08: #8807#8,80720262026-08-01: #13000#13,00020262026-10-14: #12627#12,6272026

Rank in USA: #3,017 (Jan 2022) · #3,526 (Dec 2022) · #3,584 (Jul 2023) · #2,959 (Jan 2024) · #1,649 (Mar 2026) · #2,645 (Aug 2026) · #2,530 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
7.6×
Price / book
3.5×
Free cash flow yield
-4.9%
Net margin (TTM)
-36.9%
Operating margin
-70.1%
Return on equity
-16.9%
Liabilities / assets
24.4%
Net debt
$-173M
Revenue growth
+17.7%
R&D / revenue
27.7%
Revenue per employee
$585 K
Profit per employee
$203 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2020: revenue $27M, net income $-13M$27MFY20Fiscal year ending Dec 2021: revenue $42M, net income $-22M$42MFY21Fiscal year ending Dec 2022: revenue $47M, net income $-34M$47MFY22Fiscal year ending Dec 2023: revenue $50M, net income $-36M$50MFY23Fiscal year ending Dec 2024: revenue $48M, net income $-72M$48MFY24Fiscal year ending Dec 2025: revenue $56M, net income $19M$56MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$56M+17.7%$-39M$19M34.7%
Dec 2024$48M-4.9%$-57M$-72M-151.2%
Dec 2023$50M+7.2%$-43M$-36M-72.5%
Dec 2022$47M+11.0%$-35M$-34M-71.6%
Dec 2021$42M+57.0%$-22M$-22M-52.5%
Dec 2020$27M—$-6M$-13M-47.7%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-24M$1M$-25M$0.54—
Dec 2024$-30M$1M$-31M$-2.12—
Dec 2023$-25M$2M$-27M$-1.13—
Dec 2022$-21M$2M$-23M$-1.07—
Dec 2021$-29M$1M$-30M$-0.79—
Dec 2020$4M$0M$4M$-2.35—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$66M
Net income, trailing 12 months
$-24M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $14M, net income $-19M$14MDec ’24Three months to Mar 2025: revenue $12M, net income $44M$12MMar ’25Three months to Jun 2025: revenue $13M, net income $-13M$13MJun ’25Three months to Sep 2025: revenue $14M, net income $-15M$14MSep ’25Three months to Dec 2025 (from the annual report): revenue $17M, net income $4M$17MDec ’25Three months to Mar 2026: revenue $13M, net income $-12M$13MMar ’26Three months to Jun 2026: revenue $16M, net income $-12M$16MJun ’26Three months to Sep 2026: revenue $19M, net income $-5M$19MSep ’26

Latest quarter to Sep 2026: revenue $19M (+35.4% on a year earlier), net income $-5M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of 908 Devices Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$56 M
Operating income
$-39 M
Net income
$19 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$190 M
Total liabilities
$46 M
Total equity
$144 M

As of December-2025

Top 100 institutional investors in 908 Devices Inc.#

As of Sep 30, 2026
123 institutions held 36.9 M shares (about 88.8% of the shares outstanding) on Sep 30, 2026. The ten largest hold 65.8%. Source: SEC Form 13F filings, filed through Nov 18, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in 908 Devices Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1First Light Asset Management, LLC6,641,149+358,345 (+5.70%)15.97%$82 MNov 16, 2026
2ARCH Venture Management, LLC5,725,045New13.77%$71 MNov 16, 2026
3AWM Investment Company, Inc.4,736,773-143,000 (-2.93%)11.39%$58 MNov 13, 2026
4ARK Investment Management LLC2,094,832+66,912 (+3.30%)5.04%$26 MNov 13, 2026
5BlackRock, Inc.2,045,156+100,920 (+5.19%)4.92%$25 MNov 13, 2026
6Needham Investment Management LLC1,955,000+134,380 (+7.38%)4.70%$24 MNov 16, 2026
7Vanguard Capital Management LLC1,324,267+32,697 (+2.53%)3.18%$16 MNov 13, 2026
8American Century Companies Inc1,171,644+811,796 (+225.59%)2.82%$14 MNov 12, 2026
9First Eagle Investment Management, LLC875,793-984,177 (-52.91%)2.11%$11 MNov 10, 2026
10Geode Capital Management, LLC798,858+37,061 (+4.86%)1.92%$10 MNov 6, 2026
11Lord, Abbett & Co. LLC688,494New1.66%$8 MNov 13, 2026
12State Street Corp665,954+59,394 (+9.79%)1.60%$8 MNov 12, 2026
13Granahan Investment Management, LLC516,655-175,437 (-25.35%)1.24%$6 MNov 16, 2026
14Morgan Stanley511,907+107,829 (+26.69%)1.23%$6 MNov 13, 2026
15Essex Investment Management Co LLC455,706-14,538 (-3.09%)1.10%$6 MOct 19, 2026
16Prescott Group Capital Management, L.L.C.361,5950 (0.00%)0.87%$4 MOct 30, 2026
17HighMark Wealth Management LLC339,7830 (0.00%)0.82%$4 MNov 17, 2026
18Meros Investment Management, LP333,862-27,506 (-7.61%)0.80%$4 MNov 17, 2026
19Renaissance Technologies LLC312,699+120,799 (+62.95%)0.75%$4 MNov 12, 2026
20Charles Schwab Investment Management Inc287,304+53,412 (+22.84%)0.69%$4 MNov 16, 2026
21Northern Trust Corp279,437+13,020 (+4.89%)0.67%$3 MNov 16, 2026
22Acadian Asset Management LLC219,085+148,711 (+211.32%)0.53%$3 MNov 9, 2026
23Vanguard Fiduciary Trust Co218,921+32,865 (+17.66%)0.53%$3 MNov 13, 2026
24Vanguard Portfolio Management LLC215,336+20,478 (+10.51%)0.52%$3 MNov 13, 2026
25Old Port Advisors213,364+174,735 (+452.34%)0.51%$3 MOct 23, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in 908 Devices Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Sumitomo Mitsui Trust Group, Inc.208,108-20,573 (-9.00%)0.50%$3 MOct 29, 2026
27Amova Asset Management Americas, Inc.208,108-20,573 (-9.00%)0.50%$3 MNov 13, 2026
28Dimensional Fund Advisors LP206,811+82,313 (+66.12%)0.50%$3 MNov 4, 2026
29Raymond James Financial Inc160,874-6,474 (-3.87%)0.39%$2 MNov 12, 2026
30D. E. Shaw & Co., Inc.160,064+84,618 (+112.16%)0.38%$2 MNov 16, 2026
31Campbell & CO Investment Adviser LLC156,766+45,576 (+40.99%)0.38%$2 MNov 13, 2026
32Victory Capital Management Inc155,816New0.37%$2 MNov 10, 2026
33Cassaday & Co Wealth Management LLC146,466New0.35%$2 MOct 27, 2026
34Nuveen, LLC143,450+1,723 (+1.22%)0.34%$2 MNov 10, 2026
35Legato Capital Management LLC140,902-17,217 (-10.89%)0.34%$2 MNov 10, 2026
36Perkins Capital Management Inc135,050New0.32%$2 MNov 2, 2026
37AQR Capital Management LLC133,866+29,957 (+28.83%)0.32%$2 MNov 16, 2026
38IQ EQ FUND MANAGEMENT (IRELAND) Ltd120,509+21,820 (+22.11%)0.29%$1 MNov 13, 2026
39Mitsubishi UFJ Asset Management Co., Ltd.115,169+4,612 (+4.17%)0.28%$1 MNov 5, 2026
40Millennium Management LLC113,243New0.27%$1 MNov 16, 2026
41Bank Of Montreal /can/87,3460 (0.00%)0.21%$1 MNov 9, 2026
42SEI Investments Co77,7190 (0.00%)0.19%$1 MNov 10, 2026
43Bank of New York Mellon Corp75,832+3,074 (+4.22%)0.18%$1 MNov 5, 2026
44Goldman Sachs Group Inc73,746-2,484 (-3.26%)0.18%$1 MNov 16, 2026
45Squarepoint Ops LLC73,745+36,006 (+95.41%)0.18%$1 MNov 9, 2026
46Bruce & Co., Inc.68,2860 (0.00%)0.16%$1 MNov 16, 2026
47Wealthspire Advisors, LLC67,302New0.16%$1 MNov 13, 2026
48Qube Research & Technologies Ltd66,944New0.16%$1 MNov 13, 2026
49Bank Of America Corp /de/58,356-192,671 (-76.75%)0.14%$1 MNov 16, 2026
50Citadel Advisors LLC55,754-6,993 (-11.14%)0.13%$1 MNov 16, 2026
51Nano Cap New Millennium Growth Fund L P55,000-52,500 (-48.84%)0.13%$1 MNov 13, 2026
52LPL Financial LLC54,967-484 (-0.87%)0.13%$1 MNov 6, 2026
53Bridgeway Capital Management, LLC49,661-839 (-1.66%)0.12%$1 MNov 16, 2026
54Empowered Funds, LLC49,661New0.12%$1 MNov 13, 2026
55XTX Topco Ltd44,135New0.11%$1 MNov 16, 2026
56Barclays PLC43,304+38,198 (+748.10%)0.10%$1 MNov 6, 2026
57Trexquant Investment LP40,499New0.10%$0 MNov 16, 2026
58Alliancebernstein L.P.39,5500 (0.00%)0.10%$0 MNov 16, 2026
59Quantinno Capital Management LP38,373+7,242 (+23.26%)0.09%$0 MNov 13, 2026
60Susquehanna International Group, LLP36,791+13,417 (+57.40%)0.09%$0 MNov 16, 2026
61Rhumbline Advisers36,544-247 (-0.67%)0.09%$0 MNov 10, 2026
62UBS Group AG35,610-41,806 (-54.00%)0.09%$0 MNov 10, 2026
63Deutsche Bank AG\33,002+4,590 (+16.16%)0.08%$0 MNov 6, 2026
64Pier 88 Investment Partners LLC22,600+8,400 (+59.15%)0.05%$0 MNov 6, 2026
65Price T Rowe Associates Inc /MD/22,120+1,733 (+8.50%)0.05%$0 MNov 16, 2026
66FMR LLC19,697+298 (+1.54%)0.05%$0 MNov 10, 2026
67Cresset Asset Management, LLC18,371+2,028 (+12.41%)0.04%$0 MNov 16, 2026
68MetLife Investment Management, LLC17,2920 (0.00%)0.04%$0 MNov 16, 2026
69Jpmorgan Chase & Co15,821+3,262 (+25.97%)0.04%$0 MNov 12, 2026
70MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.15,131+1,730 (+12.91%)0.04%$0 MNov 16, 2026
71Invesco Ltd.14,813-147 (-0.98%)0.04%$0 MNov 12, 2026
7249 Wealth Management, LLC13,678New0.03%$0 MNov 13, 2026
73UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC13,653+12,117 (+788.87%)0.03%$0 MNov 16, 2026
74Vanguard Global Advisers, LLC13,587+3,301 (+32.09%)0.03%$0 MNov 13, 2026
75Brevan Howard Capital Management LP12,459-8,233 (-39.79%)0.03%$0 MNov 16, 2026
76Concurrent Investment Advisors, LLC12,366+463 (+3.89%)0.03%$0 MOct 16, 2026
77Gainline Financial Partners, LLC12,3380 (0.00%)0.03%$0 MOct 15, 2026
78Graham Capital Management, L.P.10,920-3,907 (-26.35%)0.03%$0 MNov 16, 2026
79Wealth Enhancement Advisory Services, LLC10,324-1,001 (-8.84%)0.02%$0 MOct 13, 2026
80Royal Bank Of Canada9,983+5,808 (+139.11%)0.02%$0 MNov 16, 2026
81Russell Investments Group, Ltd.9,701-139,954 (-93.52%)0.02%$0 MNov 6, 2026
82Police & Firemen's Retirement System of New Jersey8,5230 (0.00%)0.02%$0 MNov 9, 2026
83Wilmington Savings Fund Society, FSB8,500New0.02%$0 MOct 23, 2026
84New York State Common Retirement Fund8,4870 (0.00%)0.02%$0 MNov 17, 2026
85BNP Paribas Financial Markets7,931+3,569 (+81.82%)0.02%$0 MNov 12, 2026
86Citigroup Inc7,517-5,912 (-44.02%)0.02%$0 MNov 4, 2026
87Wells Fargo & Company/mn6,145-18,227 (-74.79%)0.01%$0 MNov 16, 2026
88ANTIPODES PARTNERS Ltd5,931+1,937 (+48.50%)0.01%$0 MNov 5, 2026
89Tower Research Capital LLC (TRC)5,369+4,235 (+373.46%)0.01%$0 MNov 16, 2026
90Osaic Holdings, Inc.4,837-788 (-14.01%)0.01%$0 MNov 12, 2026
91Pinnacle Wealth Planning Services, Inc.4,1800 (0.00%)0.01%$0 MOct 27, 2026
92Legal & General Group Plc2,964-85 (-2.79%)0.01%$0 MNov 16, 2026
93Ameritas Investment Partners, Inc.2,7950 (0.00%)0.01%$0 MNov 13, 2026
94Group One Trading LLC2,500New0.01%$0 MNov 10, 2026
95Allworth Financial LP2,332-1,041 (-30.86%)0.01%$0 MNov 17, 2026
96Signaturefd, LLC1,4470 (0.00%)0.00%$0 MOct 23, 2026
97GAMMA Investing LLC1,216+548 (+82.04%)0.00%$0 MOct 8, 2026
98Versant Capital Management, Inc1,147+77 (+7.20%)0.00%$0 MOct 2, 2026
99Arax Advisory Partners1,050+645 (+159.26%)0.00%$0 MNov 12, 2026
100Jones Financial Companies Lllp1,048New0.00%$0 MNov 13, 2026

All 123 institutional investors, with who bought and sold →

Mutual funds holding 908 Devices Inc.#

105 funds hold shares worth $77 M (about 22.1% of the company). Since their previous reports 53 added shares and 17 sold, buying $11 M net.
Mutual funds holding 908 Devices Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 ARK Genomic Revolution ETFARK Investment Management LLC1.91 M$15 M4.6%0.98%−2.4%Jul 31, 2026
🇺🇸 Needham Aggressive Growth FundNeedham Investment Management, LLC1.40 M$12 M3.4%0.47%+51%Jun 30, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.919,827$8 M2.2%<0.01%+18%Jun 30, 2026
🇺🇸 First Eagle Small Cap Opportunity FundFirst Eagle Investment Management, LLC860,882$7 M2.1%0.24%+19%Jul 31, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors757,244$7 M1.8%<0.01%+8.3%Jun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.340,050$3 M0.82%<0.01%+9.4%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC317,090$3 M0.76%<0.01%+16%Jul 31, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors261,667$2 M0.63%0.02%+386%Jun 30, 2026
🇺🇸 Needham Small Cap Growth FundNeedham Investment Management, LLC252,970$2 M0.61%0.53%+111%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC144,417$1 M0.35%<0.01%+2.1%May 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.142,606$1 M0.34%<0.01%+5.5%May 31, 2026
🇺🇸 Victory Small Cap Stock FundVictory Capital Management Inc.149,337$1 M0.36%0.12%+0.6%Jul 31, 2026
🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.131,062$1 M0.32%<0.01%−4.6%May 31, 2026
🇺🇸 1290 Essex Small Cap Growth FundEquitable Investment Management, LLC113,551$1 M0.27%0.78%no changeJul 31, 2026
🇺🇸 Acuitas US Microcap FundAcuitas Investments, LLC100,953$1 M0.24%0.74%—Jun 30, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors97,794$1 M0.24%0.06%+40%Jun 30, 2026
🇺🇸 State Street SPDR S&P Kensho Future Security ETFSSGA Funds Management, Inc.85,312$1 M0.21%0.49%−26%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Value ETFAmerican Century ETF Trust85,296$1 M0.21%<0.01%newMay 31, 2026
🇺🇸 Bruce FundBruce and Company Inc68,286$1 M0.16%0.16%no changeJun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.71,808$1 M0.17%<0.01%+19%Jul 31, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC64,194$1 M0.15%<0.01%no changeJul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC53,796$0 M0.13%<0.01%+33%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust55,271$0 M0.13%0.02%no changeMay 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC50,500$0 M0.12%0.30%no changeJun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC51,304$0 M0.12%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC40,718$0 M0.10%0.02%+390%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC41,744$0 M0.10%<0.01%+6.7%May 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC38,433$0 M0.09%<0.01%+27%Jul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC34,750$0 M0.08%0.02%+10%Jun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC30,619$0 M0.07%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP30,370$0 M0.07%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC26,347$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.20,330$0 M0.05%<0.01%+12%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.20,322$0 M0.05%0.01%+3.0%May 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.20,374$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation18,100$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.15,916$0 M0.04%<0.01%+61%Jun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.15,777$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.15,131$0 M0.04%<0.01%+1.7%Jun 30, 2026
🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc.15,500$0 M0.04%<0.01%no changeMay 31, 2026
🇺🇸 AQR Small Cap Multi-Style FundAQR CAPITAL MANAGEMENT, LLC14,522$0 M0.03%0.03%newJun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC15,441$0 M0.04%<0.01%+12%Jul 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP15,399$0 M0.04%<0.01%−31%Jul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC13,088$0 M0.03%0.05%no changeJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC13,918$0 M0.03%<0.01%+15%Jul 31, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.10,903$0 M0.03%0.02%−3.9%Jun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company11,133$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC15,216$0 M0.04%0.06%—Mar 31, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC10,259$0 M0.02%<0.01%+2.7%Jun 30, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC10,891$0 M0.03%<0.01%+11%Jul 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.9,400$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC9,272$0 M0.02%0.01%newJun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC9,074$0 M0.02%<0.01%+51%Jun 30, 2026
🇺🇸 Small-Cap Value PortfolioPacific Life Fund Advisors LLC8,167$0 M0.02%0.02%newJun 30, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors7,945$0 M0.02%<0.01%−0.8%Jun 30, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP7,722$0 M0.02%<0.01%newJul 31, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC6,488$0 M0.02%0.03%+31%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC6,291$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS6,137$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP6,110$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC5,489$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC5,197$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION5,300$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC4,800$0 M0.01%<0.01%+200%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.4,885$0 M0.01%<0.01%+4.7%May 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.4,698$0 M0.01%<0.01%+14%Jun 30, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC4,431$0 M0.01%<0.01%+272%Jun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC4,373$0 M0.01%<0.01%+22%Jun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC4,248$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP4,574$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP4,484$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC4,331$0 M0.01%<0.01%+4.4%Jul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC3,971$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.3,692$0 M<0.01%<0.01%+37%Jun 30, 2026
🇺🇸 Column Small Cap FundTrust for Professional Managers3,672$0 M<0.01%<0.01%newMay 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC3,185$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.3,263$0 M<0.01%<0.01%+3.7%Jul 31, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC3,169$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC3,049$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management2,795$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP2,993$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP2,718$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS2,606$0 M<0.01%<0.01%+63%Jul 31, 2026
🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC2,289$0 M<0.01%0.01%+209%Jun 30, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC2,268$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC2,190$0 M<0.01%<0.01%+36%Jun 30, 2026
🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC2,382$0 M<0.01%<0.01%+773%Jul 31, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.2,153$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC1,998$0 M<0.01%<0.01%+14%Jun 30, 2026
🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC1,976$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC1,700$0 M<0.01%<0.01%−5.5%May 31, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP1,720$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC1,306$0 M<0.01%<0.01%+10%May 31, 2026
🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC1,268$0 M<0.01%<0.01%+364%Jun 30, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC1,181$0 M<0.01%<0.01%−48%Jun 30, 2026
🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP1,176$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC1,032$0 M<0.01%<0.01%−39%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC1,020$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC903$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.821$0 M<0.01%<0.01%−1.3%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at 908 Devices Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$10.3 M
59 sales, 6 insiders
Net, 12 months
-$10.3 M
open market only
Insiders on file
21
since
$293 K-$3.2 M$0Dec 2023: bought $0 (0 trades), sold $305 K (6 trades)Dec 23Feb 2024: bought $0 (0 trades), sold $237 K (9 trades)May 2024: bought $293 K (5 trades), sold $0 (0 trades)Feb 2025: bought $0 (0 trades), sold $102 K (12 trades)FebMay 2025: bought $174 K (4 trades), sold $0 (0 trades)Jun 2025: bought $0 (0 trades), sold $234 K (4 trades)Sep 2025: bought $0 (0 trades), sold $35 K (1 trades)SepOct 2025: bought $0 (0 trades), sold $45 K (2 trades)Feb 2026: bought $0 (0 trades), sold $358 K (2 trades)Mar 2026: bought $0 (0 trades), sold $49 (1 trades)MarApr 2026: bought $0 (0 trades), sold $470 K (6 trades)May 2026: bought $0 (0 trades), sold $3.0 M (13 trades)Jun 2026: bought $0 (0 trades), sold $1.5 M (12 trades)JunJul 2026: bought $0 (0 trades), sold $22 K (2 trades)Aug 2026: bought $0 (0 trades), sold $3.2 M (13 trades)Sep 2026: bought $0 (0 trades), sold $1.1 M (7 trades)SepOct 2026: bought $0 (0 trades), sold $422 K (2 trades)Nov 2026: bought $0 (0 trades), sold $329 K (1 trades)
Bought (open market)Sold (open market)Hover a month for the totals
908 Devices Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Christopher D. BrownDirectorOption exercise+54,318$1.750$95 K829,877Form 4
filed Christopher D. BrownDirectorSell10b5-1 plan-30,000$10.95$329 K775,559Form 4
filed Christopher D. BrownDirectorSell10b5-1 plan-30,000$11.89$357 K745,559Form 4
filed Christopher D. BrownDirectorOption exercise10b5-1 plan+60,000$1.750$105 K805,559Form 4
filed Joseph H. Griffith IVChief Financial OfficerSell10b5-1 plan-5,000$13.03$65 K116,497Form 4
filed AWM Investment Company, Inc.10% ownerSellindirect-18,000$11.52$207 K4.74 MForm 4
filed AWM Investment Company, Inc.10% ownerSellindirect-24,000$11.36$273 K4.75 MForm 4
filed AWM Investment Company, Inc.10% ownerSellindirect-1,000$11.25$11 K4.76 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: 908 Devices Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
2.5 M
7.0% of shares · 7.11 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2025-03-04 12:25 UTC, code T3, resumed 13:00 UTC

Fails to deliver

  • : 416 shares at $12.09
  • : 835 shares at $12.33
  • : 400 shares at $12.69
  • : 1,020 shares at $11.85
  • : 1,031 shares at $11.44

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

908 Devices Inc. scorecard#

Passes 10 of the 20 checks that could be worked out: strongest in growth (5 of 6), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 14, 2026.

  • Valuation0 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' median3.5×Price to book 3.5× against Medical Devices's median of 2.5×.
    • ✗Price to sales below its peers' median7.6×Price to sales 7.6× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%-4.9%Free cash flow is -4.9% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth5 of 6
    • ✓Revenue grew in the newest year17.7%Revenue up 17.7% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years6.2%6.2% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median6.2%6.2% a year against Medical Devices's median of 10.8% (73 companies).
    • ✓Earnings per share grew in the newest year0.54 vs -2.12Diluted EPS 0.54 in fiscal 2025 against -2.12 the year before (report's currency).
    • ✓Net income higher than five years earlier$19 M$19 M in fiscal 2025 against -$13 M in 2020.
    • ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
  • Profitability3 of 5
    • ✓Profitable in the newest year$19 MNet income $19 M in fiscal 2025.
    • ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-70.1%-70.1% against Medical Devices's median of -8.2% (86 companies).
    • ✓Return on equity above 15%15.1%15.1% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-70.1%-70.1% in fiscal 2025 against -75.5% in 2022.
  • Financial health2 of 3
    • ✓Short-term assets cover short-term liabilities4.2×Current ratio 4.24 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone5.17Z-score 5.17 (safe zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year5.3%Diluted shares up 5.3% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from 908 Devices Inc.'s statements, beside the median of Medical Devices.

908 Devices Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-70.1%-8.2%
Net margin34.7%-10.4%
Return on equity15.1%-16.8%
Revenue growth, 3 years a year6.3%10.8%
Revenue growth17.7%10.4%
Free cash flow margin-43.9%-1.9%

3of 8on the Piotroski tests of financial strength

  • Free cash flow was negative: -$25 million.
  • Only -122% of net income arrived as cash from operations.
  • The share count rose 5.3% in the year.

908 Devices Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

908 Devices Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue5648r50474227
Cost of revenue2823r25211912
Gross profit2825r25262315
Research and development1615r2218138.2
Selling, general and administrative3939r46r443213
Operating expenses6882r68614521
Operating income−39−57r−43−35−22−5.8
Interest expense and finance costs——0.20.10.51.0
Other non-operating income (expense)6.14.3r6.11.8−0.1−7.0
Income before tax−33−53r−37−34——
Income tax−0.1−0.3−0.20——
Income from continuing operations−33−53————
Income from discontinued operations53−19————
Net income including minority interests19−72−36−34−22−13
Net income attributable to shareholders19−72−36−34−22−13
Earnings per share, basic0.54-2.12-1.13-1.07-0.79-2.35
Earnings per share, diluted0.54-2.12-1.13-1.07-0.79-2.35
Shares, weighted average (basic)36343231285.5
Shares, weighted average (diluted)36343231285.5
Balance sheet
Cash and cash equivalents7144r121188224159
Short-term investments4226250——
Receivables118.9r9.010166.8
Inventory1311r15137.94.6
Other current assets7.34.2r4.24.74.50.3r
Current assets145103174216253171
Property, plant and equipment4.21.6r3.33.11.60.9
Right-of-use (leased) assets4.43.8r6.24.05.26.3
Goodwill001010——
Other intangible assets3639r7.98.5——
Total assets190159203243261179
Accounts payable1.61.4r1.21.41.41.0
Debt due within a year—————0.5
Current liabilities342523191511
Long-term debt———151514
Lease liabilities (non-current)3.92.6r3.93.04.55.8
Total liabilities464537524640
Retained earnings−223−243−171−134−101−78
Shareholders' equity144115165191215139
Total liabilities and equity190159203243261179
Shares outstanding363533323127
Cash-flow statement
Depreciation and amortization4.54.72.41.60.90.8
Share-based compensation9.8129.87.22.50.5
Cash from operating activities−24−30−25−21−294.1
Capital expenditure−1.0−0.6−2.0−2.0−0.7−0.0
Acquisitions, net of cash acquired———−14——
Cash from investing activities51−46−26−16−0.7−0.0
Cash from financing activities−0.7−0.4−161.295137
Exchange-rate effect on cash0.0−0.10.00.0——
Change in cash26−77−67−3665141
Report10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What 908 Devices Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Product revenue(total)$43 M77%
  • Device sales revenue$37 M65%
  • Recurring revenue$19 M35%
  • Service revenue(total)$13 M23%
  • Contract revenue$0 M0.2%

Business segments

  • Single reportable segment$56 M100%

Countries and regions

  • 🇺🇸 USA$41 M73%
  • Europe, Middle East and Africa$10 M19%
  • Asia Pacific$3 M5.3%
  • Americas other$2 M2.7%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at 908 Devices Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$1.6 M
Kevin J. Knopp, Ph.D. was our PEO for both years presented.
Other top executives, average
$1.2 M
the CEO earned 1.3× this
$100 invested is now
$47
908 Devices Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Kevin J. Knopp, Ph.D. was our PEO for both years presented.$1.6 M$3.0 M$1.2 M$47
2024Kevin J. Knopp$2.0 M$29 K$1.2 M$20

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at 908 Devices Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Acquisition or sale completed 3 · Directors and officers 3 · Material agreement 3 · Unregistered share sale 2 · Shareholder vote 3 · Results announced 13

908 Devices Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Shareholder vote8-K
Acquisition or sale completedMaterial agreementUnregistered share saleResults announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Shareholder vote8-K
Results announced8-K
Acquisition or sale completedMaterial agreement8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Shareholder vote8-K
Acquisition or sale completedMaterial agreementUnregistered share sale8-K
Results announced8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 10, 2026

Acquisitions and funding#

2 acquisitions, $72 M paid where reported · 5 private funding rounds before listing

Businesses it acquired

Acquisitions by 908 Devices Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
KAF Manufacturing Company2025—$3 M—Annual report
Red Wave2024—$69 M—Annual report

Private share sales · funding history

Private share sales of 908 Devices Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2019$18 MNo. 5$10 to $50 million12equitySEC
Mar 2017$24 MNo. 4$10 to $50 million13equitySEC
Apr 2015$12 MNo. 3$10 to $50 million8equitySEC
Aug 2013$7 MNo. 2$2 to $10 million7equitySEC
Jun 2012$8 MNo. 1$2 to $10 million4equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Lobbying by 908 Devices Inc.#

$290 K spent on lobbying the US Congress and federal agencies in 2025, most often on budget/appropriations, homeland security and defense.

Lobbying, 2025
$290 K
#795 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
2
in 2025
2026 so far
$218 K
  • Budget/Appropriations8 reports
  • Homeland Security7 reports
  • Defense7 reports
  • Law Enforcement/Crime/Criminal Justice7 reports

Lobbying firms hired in 2025

National Group, LLP $200 K · Brendan Neal Strategies, LLC $90 K

908 Devices Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$218 K—6
2025$290 K—8
2024$265 K—8
2023$200 K—8
2022$200 K—8
2021$80 K—5
2019$50 K—2

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “908 Devices, Inc.”, “908 Devices Inc” and “National Group LLP on Behalf of 908 Devices (fka 908 Devices, Inc.)”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

Discuss 908 Devices Inc.#

3 automatic updates and 0 member comments. Sign in to comment and react.

  • Results announced on 10 November 2026automatic update · Nov 10, 2026

    908 Devices Inc. announced results on 10 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: revenue of $19 million (up 35% from a year earlier) and a net loss of $5 million.

  • Insider trading in October 2026automatic update · Oct 31, 2026

    Directors and officers of 908 Devices Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $421,850 in 2 trades. Awards, option exercises and shares withheld for tax are not counted.

  • Mutual funds: 105 funds hold $77 millionautomatic update · Jul 31, 2026

    105 mutual funds in 1 country hold shares of 908 Devices Inc. worth $77 million, about 22.1% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 53 funds added shares and 17 sold; on balance they bought $11 million. Share splits are not counted as trading.

How 908 Devices Inc. compares in Medical Devices

  • Market cap$503 M · higher than 50% of 142
  • Revenue$56 M · higher than 29% of 155
  • Net margin-36.9% · higher than 29% of 144
  • Revenue growth17.7% · higher than 68% of 104
  • Price / sales7.6× · lower than 22% of 96
  • Price / book3.5× · lower than 41% of 99
  • FCF yield-4.9% · higher than 40% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
908 Devices Inc.🇺🇸$503 M—-36.9%+17.7%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 14, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As on September 2020
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at 908 Devices Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show 908 Devices Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about 908 Devices Inc.? Suggest a correction